Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine

• Published in: Infection and Immunity Vol. 77; no. 7; pp. 2876 - 2886
• Main Authors: Leatham, Mary P, Banerjee, Swati, Autieri, Steven M, Mercado-Lubo, Regino, Conway, Tyrrell, Cohen, Paul S
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.07.2009; American Society for Microbiology (ASM)
• Subjects: Animals; Anti-Bacterial Agents - administration & dosage; Antibiosis; Bacterial Infections; Bacteriology; Biological and medical sciences; Colony Count, Microbial; Escherichia coli; Escherichia coli - classification; Escherichia coli - growth & development; Feces - microbiology; Fundamental and applied biological sciences. Psychology; Humans; Intestines - microbiology; Mice; Microbiology; Miscellaneous; Streptomycin - administration & dosage; Human; Streptomycin; Microbiology; Digestive system; Colibacillosis; Escherichia coli; Rodentia; Gut; Immunity; Infection; Vertebrata; Antibiotic; Mammalia; Mouse; Aminoglycoside; Bacteriosis; Bacteria; Protein synthesis inhibitor; Antibacterial agent; Enterobacteriaceae

Different Escherichia coli strains generally have the same metabolic capacity for growth on sugars in vitro, but they appear to use different sugars in the streptomycin-treated mouse intestine (Fabich et al., Infect. Immun. 76:1143-1152, 2008). Here, mice were precolonized with any of three human co...